Treatments for atopic dermatitis (AD) may cause long-term ocular side effects that impair eyesight. The goal of this study is to enhance dermatologists’ knowledge of the possible ocular side effects of several AD treatments, such as corticosteroids, calcineurin inhibitors, an interleukin-4 receptor (IL-4R) antagonist, and phototherapy. Potential short- and long-term hazards of these treatments include intraocular pressure increases from topical corticosteroids and conjunctivitis from dupilumab. 

Because some of these side consequences may not manifest symptomatology until irreversible visual impairment develops, dermatologists must recognise these risks and proactively ensure their patients are getting adequate preventive treatments.